Endoglycan inhibitors represent a class of chemicals that interact with the podocalyxin like 2 protein or its associated signaling pathways to modulate its biological activity. These compounds can operate through various mechanisms to influence the function of Endoglycan. In the absence of direct inhibitors, the focus shifts to molecules that can impede or alter the signaling cascades and cellular processes where Endoglycan is a key component. The inhibitors can target upstream kinases, phosphatases, or other regulatory proteins that govern the activation state of Endoglycan. By influencing these regulatory mechanisms, the inhibitors can change the phosphorylation pattern of Endoglycan, which is critical for its cellular localization, stability, and interaction with other cellular components. Furthermore, these inhibitors can also affect the downstream effects of Endoglycan activation, such as alterations in the cytoskeletal arrangement, cellular adhesion, and migration.
The chemical entities classified as Endoglycan inhibitors may vary widely in structure and specificity, but they share the ability to modulate the biological processes associated with Endoglycan. The activity of these compounds can be traced through their impact on the protein's interaction networks and the cellular functions it influences. Inhibition can occur through the modulation of lipid kinase pathways, which are pivotal for maintaining cellular survival signals and the dynamics of cell adhesion and motility. The inhibitors can also engage with mitogen-activated protein kinase (MAPK) pathways, altering the cellular response to stress and affecting the cell cycle. The diversity in the action of these inhibitors reflects the complex web of interactions that Endoglycan engages within the cellular environment. By changing the activity of specific kinases or phosphatases, the inhibitors can bring about changes in the phosphorylation status of Endoglycan, thus affecting its function. The breadth of this inhibitor class is a testament to the intricate nature of cellular signaling and the nuanced approach required to modulate specific protein functions within these networks.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is an isoflavone from soy products that acts as a tyrosine kinase inhibitor, potentially altering the phosphorylation state of proteins like Endoglycan, affecting their function and cellular localization. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a steroidal metabolite of fungi which acts as a PI3K inhibitor, potentially disrupting signaling pathways that Endoglycan may be involved in, affecting cellular processes like migration. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a synthetic molecule that inhibits PI3K, which can modulate signaling pathways potentially involving Endoglycan, impacting processes such as cell survival and adhesion. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a synthetic compound that inhibits MEK, which indirectly could affect the ERK pathway, potentially altering the function of proteins like Endoglycan in cellular proliferation and differentiation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a pyridinyl imidazole that acts as a p38 MAPK inhibitor, potentially influencing signaling pathways that could affect Endoglycan function in inflammatory responses and cell cycle regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an anthrapyrazolone inhibitor of JNK, which can modulate signaling pathways possibly involving Endoglycan, impacting cellular processes like apoptosis and cytokine production. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor, which could alter signaling pathways involving Endoglycan, potentially affecting cell adhesion and migration. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a multi-targeted tyrosine kinase inhibitor, which may indirectly affect the phosphorylation state of Endoglycan, influencing cell adhesion and migration. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
AG490 is a tyrosine kinase inhibitor, which can indirectly affect JAK/STAT signaling pathways potentially involving Endoglycan, impacting processes such as cell growth and apoptosis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is a macrolide compound that inhibits mTOR, potentially affecting signaling pathways involving Endoglycan, impacting cell growth and proliferation. | ||||||